Prostate Cancer News

Cancer diagnoses fell significantly below expectations in 2020 due to the COVID-19 pandemic but recovered to projected levels the following year, according to results of a cross-sectional study.

One journal reviewer told Donald P. McDonnell, PhD, the research should be “banned from the literature.”

Certain pesticides may increase the risk for prostate cancer incidence and mortality, according to results of an environment-wide association study.

Lack of health insurance contributes to a high percentage of racial and ethnic disparities in advanced-stage diagnoses for several cancer types, according to results of a mediation analysis.

A transperineal approach to prostate cancer biopsies without the need for preventive antibiotics could eliminate risk for infection, according to results of a randomized trial.

People with cancer had more than double the risk for COVID-19 mortality than the general population, according to study results.

Five-fraction stereotactic body radiotherapy proved noninferior to conventional radiotherapy with regard to biochemical or clinical failure for men with localized prostate cancer, according to randomized phase 3 study results.

Enzalutamide conferred small but statistically significant improvements in outcomes vs. abiraterone acetate for men with metastatic castration-resistant prostate cancer, according to retrospective study results.

The addition of talazoparib to enzalutamide extended OS among men with metastatic castration-resistant prostate cancer, according to the agent’s manufacturer.